GUARDANT HEALTH INC (GH)

US40131M1099 - Common Stock

17.16  -0.94 (-5.19%)

After market: 17.37 +0.21 (+1.22%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to GH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 39.84. This target is 132.17% above the current price.
GH was analyzed by 30 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about GH.
In the previous month the buy percentage consensus was at a similar level.
GH was analyzed by 30 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 17.1627.2740.8039.8456.70 - 58.92% 137.76% 132.17% 230.42%
Up and Down Grades
Date Firm Action Rating
2024-04-15 Goldman Sachs Maintains Buy -> Buy
2024-04-05 Guggenheim Reiterate Neutral
2024-02-26 Piper Sandler Maintains Overweight -> Overweight
2024-02-23 JP Morgan Maintains Overweight -> Overweight
2024-02-23 Canaccord Genuity Maintains Buy -> Buy
2024-01-30 Goldman Sachs Maintains Buy -> Buy
2024-01-29 Goldman Sachs Maintains Buy -> Buy
2023-12-14 Guggenheim Initiate Neutral
2023-12-13 Wolfe Research Initiate Peer Perform
2023-11-13 Raymond James Upgrade Market Perform -> Outperform
2023-11-08 Morgan Stanley Maintains Overweight -> Overweight
2023-10-23 Goldman Sachs Maintains Buy -> Buy
2023-10-20 Goldman Sachs Maintains Buy -> Buy
2023-10-02 Citigroup Reiterate Buy -> Buy
2023-09-28 Bernstein Initiate Outperform
2023-09-27 Piper Sandler Upgrade Neutral -> Overweight
2023-08-08 Piper Sandler Maintains Neutral -> Neutral
2023-08-07 Morgan Stanley Maintains Overweight -> Overweight
2023-08-04 Citigroup Maintains Buy -> Buy
2023-05-26 Citigroup Upgrade Neutral -> Buy
2023-05-11 Morgan Stanley Maintains Overweight -> Overweight
2023-05-10 Credit Suisse Maintains Outperform
2023-05-01 OTR Global Downgrade Mixed -> Negative
2023-03-09 Citigroup Downgrade Buy -> Neutral
2023-03-03 Piper Sandler Maintains Neutral
2023-02-27 Morgan Stanley Maintains Overweight
2023-02-24 BTIG Maintains Buy
2023-02-24 Cowen & Co. Maintains Outperform
2023-02-24 JP Morgan Maintains Overweight
2023-02-24 Canaccord Genuity Maintains Buy